Recognition Marks the Company’s Second Straight Year on the Prestigious List of America’s Fastest-Growing Private Companies - and Comes as Claritas Rx Celebrates 15 Years Partnering with Life Sciences Clients

SOUTH SAN FRANCISCO, Calif.: Claritas Rx, the patient journey experts, announced today it has been named to the 2026 Inc. 5000 list for the second consecutive year, earning a place among America's fastest-growing private companies. The list is the most prestigious ranking of the nation’s most successful independent and entrepreneurial businesses, recognizing companies that have achieved remarkable growth while driving innovation, creating jobs, and shaping the future of the economy. Past honorees include companies such as Microsoft, Meta, Chobani, Oracle, and Patagonia.

The back-to-back honor comes as Claritas Rx marks 15 years in business, a milestone that underscores the company's long-standing role as a trusted partner to biopharma companies working to help patients start and stay on therapy.

"We are honored to be named to the Inc. 5000 for the second consecutive year," said Michael Fitzgibbons, CEO of Claritas Rx. "This year is especially meaningful, as it also marks 15 years of Claritas Rx being a trusted partner to our clients. That commitment is what has fueled our growth year after year. Making this list twice in a row is a reflection of the trust our clients place in us, and of a team that stays focused on our promise: progress for every patient journey."

For the full Inc. 5000 list, honoree company profiles, and a searchable database by industry and location, please visit: www.Inc.com/Inc5000.

“Every company on the Inc. 5000 has a story of perseverance, smart decision making, and a refusal to sit still,” says Mike Hofman, editor-in-chief of Inc. “Their growth reflects more than strong financial performance–it reflects creativity, resilience, and the customer focus required to build companies that make a lasting impact. We congratulate all honorees on this significant achievement.”

About Inc.

Inc. is the leading media brand and playbook for the entrepreneurs and business leaders shaping our future. Through its journalism, Inc. aims to inform, educate, and elevate the profile of its community: the risk-takers, the innovators, and the ultra-driven go-getters who are creating the future of business. Inc. is published by Mansueto Ventures LLC, along with fellow leading business publication Fast Company. For more information, visit www.Inc.com.

About Claritas Rx

Based in South San Francisco, CA, Claritas Rx helps rare disease and specialty brands remove the barriers that keep patients from accessing and staying on the treatments they need. Currently celebrating its 15-year anniversary, the company unites the most complete view of the patient journey with purpose-built technologies to predict and resolve access challenges before they disrupt care. Our intelligent solutions combine advanced analytics, real-world data, AI, and in-line CRM capabilities to increase start and refill rates, reduce abandonment, and improve brand performance. For more information, visit www.ClaritasRx.com.

Fonte: Business Wire